| Literature DB >> 20144201 |
Demba Sarr1, Delphine Aldebert, Laurence Marrama, Emilie Frealle, Alioune Gaye, Hamoud O Brahim, Makhtar Niang, Jean Marie Dangou, Odile Mercereau-Puijalon, Jean Yves Lehesran, Ronan Jambou.
Abstract
BACKGROUND: Placental malaria (PM) is associated with poor foetal development, but the pathophysiological processes involved are poorly understood. Cyclooxygenase (COX) and lipoxygenase (LOX) which convert fatty acids to prostaglandins and leukotrienes, play important roles in pregnancy and foetal development. COX-2, currently targeted by specific drugs, plays a dual role as it associates with both pre-eclampsia pathology and recovery during infection. The role of COX during PM was questioned by quantifying at delivery COX-1, COX-2, 15-LOX, and IL-10 expression in two groups of malaria infected and uninfected placenta.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20144201 PMCID: PMC2831904 DOI: 10.1186/1475-2875-9-45
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Nucleotides sequences of the primers and probes used for real time PCR. PPIA: Peptidyl Propyl Isomerase A.
| Human Gene | Accession number | Sequences | Amplicon size (bp) |
|---|---|---|---|
| COX-1 | a) Fam-CTG GCC TCA GCA CTC TGG AAT GAC AA-Tamra | 150 | |
| COX-2 | a) Fam-TGC CCA GCA CTT CAC GCA TCA GTT-Tamra | 79 | |
| 15-LOX | a) Fam-TCC ACC AGG CTT CTC TCC AGA TGT CC-Tamra | 74 | |
| PPIA | a)Fam-AGC TCA AAG GAG ACG CGG CCC A-Tamra | 73 | |
| IL-10 | a)Fam-CAG GCA ACC TGC CTA ACA TGC TTC-Tamra | 70 |
Clinical and laboratory data of enrolled women according to the class of infection.
| Variables | Ctrl | Total | NP | Past I | Acute I | Chronic I |
|---|---|---|---|---|---|---|
| No. of women | 14 | 40 | 10 | 10 | 10 | 10 |
| Primigravidae n (%) | 4 (28) | 13 (32.5) | 3 (30) | 3 (30) | 3 (30) | 4 (40) |
| Secundigravidae n (%) | 5 (36) | 13 (32.5) | 3 (30) | 3 (30) | 3 (30) | 3 (30) |
| Multigravidae n (%) | 5 (36) | 14 (35) | 4 (40) | 4 (40) | 4 (40) | 3 (30) |
| Age (years) | 24.6 ± 1.6 | 25.6 ± 1.13 | 25.2 ± 2.3 | 26.6 ± 0.6 | 26.0 ± 1.96 | 24.8 ± 2.3 |
| Pregnancy duration, weeks | 40.8 ± 1.2 | 40.5 ± 2.6 | 41.1 ± 1.1 | 40.9 ± 0.9 | 41.1 ± 1.1 | 41.3 ± 1.3 |
| Birth weight (g) | 3,153 ± 93 | 2,723 ± 93* | 2,995 ± 137 | 2,623 ± 131* | 2,862 ± 167 | 2,411 ± 251* |
| Haemoglobin (g/dl) | 11.9 ± 0.3 | 9.4 ± 2.5* | 10.2 ± 1.2 | 8.5 ± 0.4* | 8.4 ± 1.1* | 10.2 ± 0.9 |
| Parasitaemia, Venous | 0 | 83% | 0 | 0 | 205.5% | 35.3% |
| Parasitaemia, Placental | 0 | 294% | 0 | 0 | 644.5% | % |
(*) means significant when compared with the control group (p < 0.05)
NP (no parasites): PfHRP2 positive placenta without parasites or pigment detected by microscopy; PI (past infection): only pigment detected by microscopy; AI (acute infection): only parasites detected; CI (chronic infection): parasites and pigment detected; control (Ctrl): uninfected women with PfHRP2 negative placenta. Data are mean ± SE. Parasitaemia are expressed as parasites per 100 leukocytes. (*) significant difference with control group (p < 0.01 Mann Whitney U test).
Figure 1Expression of COX-1, COX-2, 15-LOX and IL-10 mRNA in placenta. Expression levels was calibrated for each gene using PPIA as housekeeping gene (delta Ct = Ctgene - CtPPIA) and normalized using the pool of uninfected control placentas (delta delta Ct = delta Ct - mean delta Ct (ctrl)). Results are plotted according to: (A) infection classes: CI = Chronic Infections, AI = Acute Infections, PI = Past Infections, NP = No parasites/pigment detectable, Ctrl = uninfected placentas (PfHRP2-) (B) Parity: P = primiparous, M = multiparous, and S = secondiparous women. RQ = Relative Quantity = 2-(deltadelta Ct). P value are indicated for significant test only (p < 0.05).
Figure 2Expression of COX-1, COX-2, 15-LOX and IL-10 mRNAs in placenta. Expression levels of each gene (calibrated as in Fig.1) plotted according to (A) haemoglobin level of the mother (g/100 ml) (B) Birth weight of the newborn. Hb = hemoglobin; BW = birth weight; RQ = Relative quantity. P value are indicated for significant test only.
Figure 3Impact of the charge of pigment in the placenta. For PfHRP2+ placenta, the pigment deposit was plotted as: "no pigment" (No); "low load of pigment" (low) for less than 3 pigments for 10 field (×400); "high load of pigment" (high) for more than 3 pigments per field; "control group" (Ctrl) for PfHRP2- placenta. A) Relation between charge in pigment and birth weight of the newborn (g), B) Relation between charge in pigment and haemoglobin level of the mother (g/100 ml), C) Relation between charge in pigment and count of CD68+ and HLA-DR cells in the placenta (number of cells/100 fields at magnification ×400). D) Relation between charge in pigment and expression level of the four genes (RQ = Relative Quantity = 2-(deltadelta Ct)). NS = not significant, (*) means significant when compared with the control group.